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cannabis and cocaine (e.g. cannabis, OR 3.18, 2.75 to 3.70). All significant 
differences survived controls for age and ethnicity. After adjustment for il-
licit substance use gender differences in aggression, agitation, paranoia and 
grandiosity became insignificant (p > 0.05). However, adjustment for illicit 
substance use resulted in increased strength of gender associations with 
negative, manic and depression symptoms.
Discussion: There are clear gender differences in the clinical presentation 
of FEP which are modified by exposure to illicit substances. These findings 
highlight a need to better understand the impact of gender on clinical pres-
entation and treatment outcomes in psychosis, and to ensure that clinicians 
are aware of how gender differences in presentation could be modified by 
illicit substance use.
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Background: There is evidence of higher rates of insecure and disorgan-
ized attachment in infancy in children born to parents with severe mental 
disorders, but evidence on attachment in middle childhood for these children 
is lacking. This study aims to explore attachment representations in seven-
year-old children born to parents with schizophrenia or bipolar disorder. We 
also aim to explore possible associations between attachment and psycho-
pathology, level of functioning, and psychotic experiences in these children.
-  We expect that children at familial high risk will have the highest levels of 
insecure and disorganized attachment. We expect that population based 
controls will have the lowest levels of insecure and disorganized attach-
ment and higher levels of security than children at familial high risk.
-  We expect higher levels of insecure and disorganized attachment to be 
associated with an increased risk of psychopathology, and psychotic 
experiences and with lower levels of functioning, whereas we expect 
higher levels of secure attachment to be associated with a lower risk of 
psychopathology, and psychotic experiences, and with higher levels of 
functioning.
Methods: The Danish High Risk and Resilience Study VIA 7 is a prospec-
tive cohort study of 522 seven-year-old children born in Denmark. The 
cohort consists of children where one or both parents have been diagnosed 
with a schizophrenia spectrum disorder (N=202), children where one or 
both parents have been diagnosed with bipolar affective disorder (N=120) 
and children where neither of the parents have been diagnosed with 
these disorders (N=200). Attachment representations were assessed with 
the Story Stem Assessment Protocol whereas psychopathology, level of 
functioning, and psychotic experiences were assessed with K-SADS.
Results: Data analyses are ongoing but preliminary results indicate that 
there are no significant differences in attachment representations between 
the three groups of children, but that there are associations between higher 
rates of insecure and disorganized attachment and a higher risk of psycho-
pathology. Results will be presented at the SIRS-conference.
Discussion: Understanding attachment and its correlates in children 
at familial high risk of severe mental disorders is important in order to 
strengthen our understanding of developmental trajectories towards 
mental disorders in these children.
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Background: Drug development is a billion dollar business globally. It is 
crucial to stay up to date on drug developments all over the world any 
repetition will be irreversible waste of resources. The only way to keep up 
with all the development is to keep a living database of all trials running 
for each condition and covering all studies from every country in any lan-
guage. An Information Specialist collects and classifies all pharmacological 
interventions from all schizophrenia trials.
Methods: Cochrane Schizophrenia’s Study-Based Register was devel-
oped and used as the source of trials, Emtree and MeSH for synonyms, 
AdisInsight and CT.gov for research drugs and WHO ATC for marketed 
drugs. This research took four years from 17 December 2014 and 6 January 
2019 and involved 18,500 randomized controlled trial from 90 countries in 
23 languages.
Results: One third of tested interventions on patients with schizophrenia 
are pharmacological (816; belonging to 106 clinical classes) with anti-
psychotic drugs being the most researched (15.1%). Only 528 of these 
medications are listed in WHO ATC. Around one third of these drug 
interventions are seen only in research (236; from 21 pharmacological/bi-
ochemical classes). Within the pharmacological evaluations we identified 
28  ‘qualifiers’ including dose, route, and timing of drug delivery. Using 
Data Science approaches, this research revealed unique antipsychotic drugs 
that are being prescribed only in certain countries such as Japan but the 
West is not aware of them. This research is also revealed all the research 
drugs and current trends in developing drugs in pharmaceutical companies.
Discussion: Classification of medication interventions from trials requires 
use of many sources of information none of which are inclusive of all drugs. 
Without a global search in all languages the pharmaceutical companies 
and researchers are missing important successful developments from non-
English speaking world. The cycle of developing research/withdrawn drugs 
does not stop and may end in veterinary medicine, doping agents in sports, 
and illicit drug market.
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Background: Insufficient mental health literacy (MHL) of the general 
public is one of the major factors that prevent early intervention for mental 
illness. Insufficient MHL may exacerbate the stigma attached to people 
with mental illness. In Japan, there have been few large-scale surveys to 
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